Troy Cox serves as Executive at Foundation Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Troy Cox has executed 18 insider transactions totaling $3.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 28, 2024 involved receiving (via award) 43,128 shares valued at $0.
Troy Cox currently holds 161,820 shares of Foundation Medicine, Inc. (FMI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Troy Cox has been a net seller of FMI stock. They have purchased $348.8K and sold $3.3M worth of shares.
Troy Cox's most recent insider trade was on Jun 28, 2024, when they sold 43,128 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 5, 2024 | LAB | $0 | Award | 87,057 | $N/A | Discretionary |
| Jan 5, 2024 | LAB | $0 | Award | 31,635 | $N/A | Discretionary |
| Jan 5, 2024 | SLGC | $0 | Disposition | 78,430 | $N/A | Discretionary |
| Mar 17, 2023 | SLGC | $0 | Award | 28,500 | $N/A | Discretionary |
| Mar 1, 2022 | SLGC | $0 | Award | 3,430 | $N/A | Discretionary |
| Sep 1, 2021 | SLGCW | $500.0K | Award | 50,000 | $10.00 | Discretionary |
| Sep 1, 2021 | SLGCW | $0 | Other | 25,000 | $N/A | Discretionary |
| Jan 27, 2020 | ZYME | $348.8K | Purchase | 7,500 | $46.50 | Discretionary |
| Jul 31, 2018 | FMI | $28.3M | Other | 206,847 | $137.00 | Discretionary |
| Jul 31, 2018 | FMI | $4.8M | Tender | 35,221 | $137.00 | Discretionary |
| Jul 2, 2018 | FMI | $191.6K | Sale | 1,402 | $136.66 | Discretionary |
| May 16, 2018 | FMI | $166.3K | Sale | 2,157 | $77.10 | Discretionary |
| May 7, 2018 | FMI | $494.5K | Sale | 7,063 | $70.01 | Discretionary |
| Apr 1, 2018 | FMI | $2.9M | Award | 37,357 | $78.75 | Discretionary |
| Feb 15, 2018 | FMI | $605.8K | Sale | 9,012 | $67.22 | Discretionary |
| Feb 7, 2018 | FMI | $1.9M | Sale | 26,713 | $70.13 | Discretionary |